Abstract
Extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTCL) is a rarely kind of non-Hodgkin lymphoma (NHL). It is much more frequent in Asian and Latin American countries than other part of the world. It typically affects nasal cavity. In China, one of its endemically places, ENKTCL accounts for 74%–96% of nasal NHL. Patients with ENKTCL usually show a highly aggressive clinical course, and its etiology is unclear. However, it is already proved that ENKTCL is associated with Epstein-Barr virus (EBV) infection, regardless patients’, ethnicity and areas. Some studies show that the risk will increase among several occupations, such as farmer, who are frequently exposure to pesticides and chemical solvent and risk can be cut down if taking some protective measures.
Similar content being viewed by others
References
McBride P. Photographs of a case of rapid destruction of the nose and face. 1897. J Laryngol Otol, 1991, 105: 1120.
Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting — Airlie House, Virginia, November 1977. J Clin Oncol, 1999, 1: 3835–3849.
Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International lymphoma Study Group. Blood, 1994, 5: 1361–1392.
AI-Hakeem DA, Fedele S, Carlos R, et, al. Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol, 2007, 43: 4–14.
Wang DB, Ming M, Liu JH, et al. The significance and features of apoptosis and proliferation of NK/T cell lymphoma. Chinese-German J Clin Oncol, 2011, 10: 286–289.
Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin’s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer, 1998, 83: 449–456.
Kim BS, Kim DW, Im SA, et al. Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone. Ann Oncol, 2009, 20: 121–128.
Zhang XX, Xie CH, Xu Y, et, al. Salvage treatment improved survival of patients with relapsed extranodal natural killer/t-cell lymphoma, nasal type. Int J Radiat Oncol Biol Phys, 2009, 74: 747–752.
Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin’s lymphoma of the nasal cavity: prognostic significance of paranasal extention and the role of radiotherapy and chemotherapy. Cancer, 1998, 83: 449–456.
Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nansal lymphoma. J Clin Oncol, 1995, 13: 666–670.
Yu JB, Zuo Z, Tang Y, et al. Extranodal nasal-type natural killer/T-cell lymphoma of the skin: a clinicopathologic study of 16 cases in China. Hum Pathol, 2009, 40: 807–816.
Suzuki R, Takeuchi K, Ohshima K, et al. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol, 2008, 26: 66–72.
Rodriguez J, Romaguera JE, Manning J, et al. Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases. Leuk Lymphoma, 2000, 39: 139–144.
Quintanilla-Martinez L, Franklin JL, Guerrero I, et al. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression. Hum Pathol, 1999, 30: 849–855.
Xu JX, Hoshida Y, Yang WI, et al. Life-style and environmental factors in the development of nasal NK/T-cell lymphoma: a case-control study in East Asia. Int J Cancer, 2007, 120: 406–410.
Kojya S, Matsumura J, Ting L, et al. Familial nasal NK/T-cell lymphoma and pesticide use. Am J Hematol, 2001, 66: 145–147.
Zhang Y, Holford TR, Leaderer B, et al. Hair-coloring product use and risk of non-Hodgkin’s lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol, 2004, 159: 148–154.
Harabuchi Y, Yamanaka N, Kataura A, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 1990, 335: 128–130.
Chan JKC, Quintanilla-Martinez L, Ferry JA, et al. “Extranodal NK/T-cell lymphoma, nasal type,” in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer. 2008. 285–288.
Hsieh PP, Tung CL, Chan AB, et al. EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma. Am J Clin Pathol, 2007, 128: 579–584.
Barrionuevo C, Zaharia M, Martinez MT et al. Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru. Appl Immunohistochem Mol Morphol, 2007, 15: 38–44.
Borisch B, Henning I, Laeng RH, et al. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin’s lymphoma of the midline granuloma type. Blood, 1993, 82: 858–864.
Tomita Y, Ohsawa M, Qiu K, et al. Epstein-Barr virus in lymphoproliferative diseases in the sino-nasal region: close association with CD56+ immunophenotype and polymorphic reticulosis morphology. Int J Cancer, 1997, 70: 9–13.
Kim JE, Kim YA, Jeon YK, et al. Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1. Pathol Int, 2003, 53: 735–743.
Tomita Y, Ohsawa M, Mishiro Y, et al. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan. Lab Invest, 1995, 73: 190–196.
Hirakawa S, Kuyama M, Takahashi S, et al. Nasal and nasal-type natural killer/T-Cell lymphoma. J Am Acad Dermatol, 1999, 40: 268–272.
Kuo TT, Shih LY, Tsang NM, et al. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 case, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol, 2004, 12: 375–387.
Wu X, Li P, Zhao J, et al. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clin Oncol (R Coll Radiol), 2008, 20: 619–625.
Ng SB, Lai KW, Murugaya S, et al. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol, 2004, 17: 1097–1107.
Altemani A, Barbosa AC, Kulka M, et al. Characteristics of nasal T/NK-cell lymphoma among Brazilians. Neoplasma, 2002, 49: 55–60.
Pagano L, Gallamini A, Trape G, et al. NK/T-cell lymphomas’ nasal type’: an Italian multicentric retrospective survey. Ann Oncol, 2006, 17: 794–800.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liao, Y., Du, X. & Zou, Q. Extranodal natural killer/T-cell lymphoma, nasal type: epidemiology study. Chin. -Ger. J. Clin. Oncol. 11, 290–293 (2012). https://doi.org/10.1007/s10330-012-0962-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-012-0962-4